Figure 3.
Time to cardiovascular death or first hospitalization for heart failure in key prespecified and post hoc subgroups. BMI indicates body mass index; CVD, cardiovascular disease; GLP-1RA, glucagon-like peptide 1 receptor agonist; PY, patient-years; and SGLT-2i, sodium-glucose cotransporter-2 inhibitor.